Together, these results strongly suggest that KEAP1 deficiency upregulates FSP1 levels and that the CoQ-FSP1 signaling axis plays an important role in mediating ferroptosis resistance to class 2 FINs in KEAP1 deficient lung cancer cells. The gene discussed is AIFM2; the disease is lung carcinoma.